Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review

Abstract Background Upper tract urothelial carcinoma (UTUC) is a rare subtype of urothelial cancer, accounting for only 5–10% of cases, and is characterized by aggressive biological behavior. Recent advances in immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) have expanded the...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Peng Ding, Huanhuan Lin, Kaichen Zhang, Qian Yang, Peiyang Gao
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2025-07-01
Σειρά:	BMC Pulmonary Medicine
Θέματα:	Toripalimab Disitamab Vedotin Interstitial lung disease Upper tract urothelial carcinoma Glucocorticoid Case report
Διαθέσιμο Online:	https://doi.org/10.1186/s12890-025-03838-z
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!